Accenture slips as Truist downgrade highlights AI competition and federal-spending pressure

Accenture plc (ACN) is down 5.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a bearish analyst reset that emphasized near-term demand risk for traditional consulting work as clients push productivity with AI and keep budgets tight. Ongoing investor sensitivity around Accenture’s U.S. federal exposure likely amplified the selling pressure.

Details:

An analyst at Truist moved Accenture to a Hold rating and set a $210 price target, citing concerns that AI could cannibalize parts of Accenture’s core services mix and that client budgets remain under pressure.

Accenture’s fiscal 2026 outlook has already baked in a headwind from its U.S. federal business (roughly a 1% drag referenced in company guidance), which has been a recurring focus for investors.

In April 2026, federal agencies terminated for cause a Military OneSource award held by Cognosante, which had been acquired by Accenture; the program was subsequently awarded to a different prime contractor.

With the next earnings report expected later in June, positioning and risk-reduction ahead of results could be contributing to the magnitude of the one-day decline.

Sources:

Investing.com, Accenture Investor Relations, Washington Technology

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ACN Insider Trading Activity

$ACN insiders have traded $ACN stock on the open market 75 times in the past 6 months. Of those trades, 0 have been purchases and 75 have been sales.

Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:

JULIE SPELLMAN SWEET (Chair and CEO) has made 0 purchases and 23 sales selling 13,251 shares for an estimated $3,282,602.
JOHN F WALSH (CEO-The Americas) has made 0 purchases and 9 sales selling 4,000 shares for an estimated $1,105,033.
MELISSA A BURGUM (Chief Accounting Officer) has made 0 purchases and 6 sales selling 3,603 shares for an estimated $1,012,037.
ATSUSHI EGAWA (Co-CEO Asia Pacific) has made 0 purchases and 4 sales selling 4,872 shares for an estimated $863,044.
MANISH SHARMA (Chief Strategy & Services Ofcr) has made 0 purchases and 8 sales selling 2,829 shares for an estimated $811,405.
JOEL UNRUCH (General Counsel/Corp Secretary) has made 0 purchases and 5 sales selling 2,358 shares for an estimated $655,324.
KATHERINE LEE CLIFFORD (Chief Leadership & HR Officer) has made 0 purchases and 13 sales selling 1,468 shares for an estimated $412,092.
MAURO MACCHI (Chief Executive Officer-EMEA) has made 0 purchases and 2 sales selling 1,000 shares for an estimated $280,000.
CATHERINE KIERNAN HOGAN (Chief Operating Officer) has made 0 purchases and 5 sales selling 660 shares for an estimated $185,412.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive ACN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$ACN Hedge Fund Activity

We have seen 940 institutional investors add shares of $ACN stock to their portfolio, and 1,407 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 14,072,672 shares (+259.3%) to their portfolio in Q1 2026, for an estimated $2,774,849,464
CAPITAL INTERNATIONAL INVESTORS removed 13,358,309 shares (-76.5%) from their portfolio in Q1 2026, for an estimated $2,633,991,368
WELLINGTON MANAGEMENT GROUP LLP removed 6,741,493 shares (-64.2%) from their portfolio in Q1 2026, for an estimated $1,329,287,589
MORGAN STANLEY added 3,885,528 shares (+51.6%) to their portfolio in Q1 2026, for an estimated $766,148,411
PRICE T ROWE ASSOCIATES INC /MD/ removed 2,920,256 shares (-61.2%) from their portfolio in Q1 2026, for an estimated $575,816,078
HARRIS ASSOCIATES L P added 2,891,902 shares (+inf%) to their portfolio in Q1 2026, for an estimated $570,225,236
UBS GROUP AG added 2,164,229 shares (+80.8%) to their portfolio in Q1 2026, for an estimated $426,742,674

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ACN Government Contracts

We have seen $3,128,539,325 of award payments to $ACN over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

THIS TASK ORDER IS FOR AN ENTERPRISE-WIDE DIGITAL AND CUSTOMER CARE PLATFORMS AND SERVICES SOLUTION (ENTERP...: $215,473,554
FEDERALLY FACILITATED EXCHANGE (FFE): $185,678,383
TITLE IV FINANCIAL AID ORIGINATION AND DISBURSEMENT (TIVOD) SYSTEMS AND CUSTOMER SERVICE TRANSITION SERVICES: $183,644,413
SEE CONTRACT SCHEDULE, ATTACHMENTS, AND EXHIBITS.: $181,476,368
VBA DGIB SUPPORT SERVICES PURCHASE: $176,293,546

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$ACN Congressional Stock Trading

Members of Congress have traded $ACN stock 8 times in the past 6 months. Of those trades, 2 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 03/13, 12/19 and 2 sales worth up to $30,000 on 04/14, 02/10.
REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 03/23.
REPRESENTATIVE KEVIN HERN sold up to $500,000 on 03/16.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$ACN Analyst Ratings

Wall Street analysts have issued reports on $ACN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 12/19/2025
UBS issued a "Buy" rating on 12/19/2025

To track analyst ratings and price targets for $ACN, check out Quiver Quantitative's $ACN forecast page.

$ACN Price Targets

Multiple analysts have issued price targets for $ACN recently. We have seen 14 analysts offer price targets for $ACN in the last 6 months, with a median target of $251.5.

Here are some recent targets:

Bryan Keane from Citigroup set a target price of $195.0 on 06/01/2026
Arvind Ramnani from Truist Securities set a target price of $210.0 on 06/01/2026
Dan Dolev from Mizuho set a target price of $280.0 on 03/23/2026
Tien-Tsin Huang from JP Morgan set a target price of $247.0 on 03/20/2026
Keith Bachman from BMO Capital set a target price of $230.0 on 03/20/2026
Jonathan Lee from Guggenheim set a target price of $250.0 on 03/20/2026
Daniel R. Perlin from RBC Capital set a target price of $253.0 on 03/20/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.